1Easton JD.Future perspectives for optimizing oral antiplatelet therapy(J).Cerebrovasc Dis,2001;11(1):23-8.
2Iwamoto T,Kubo H,Takasaki M.Platelet activation in the cerebral circu-lation in different subtypes of ischemic stroke and Binswanger's disease(J).Stroke,1995;26(1):52-6.
3Grau AJ,Ruf A,Vogt A,et al.Increased fraction of circulating aetivateel platelets in acute and previous cerebrovascular ischemia(J).Thromb Haemost,1998;80:298-301.
6Antiplatelet Trialists'Collaboration.Collaborative overview of randomized trials of antiplatelet therapy,I:prevention of death,myocardial infarction,and stroke by prolonged antiplatelet therapy in various categories of pa-tients(J).BMJ,1994;308:81-106.
7Johnson ES,Lanes SF,Wentworth CE,et al.A meta-regression analysis of the dose-response effect of aspirin on stroke(J).Arch Intern Med,1999;159:1248-53.
8Diener HC,Cunha L,Forbes C,et al.European Stroke Prevention Stud-y.Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke(J).J Neurol Sci,1996;143(1-2):1-13.
10Sacco RL,Adams R,Albers G,et al.American Heart Association;Amer-ican Stroke Association Council on Stroke;Council on Cardiovascular Radiology and Intervention;American Academy of Neurology.Guidelines for prevention of stroke in patients with ischemic stroke or transient is-chemic attack:a statement for healthcare professionals from the Ameri-can Heart Association/American Stroke Association Council on Stroke:co-sponsored by the Council on Cardiovascular Radiology and Interven-tion:the American Academy of Neurology affirms the value of this guide-line(J).Stroke,2006;37(2):577-617.
7Antithrombotic TC.Collaborative meta-analysls of randomized trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324:71-86.
8Anderson S,Emery J,Baglin T,et al.Narrative review:aspirin resistance and its clinical implications.Ann Intern Med,2005,142:370-380.
9Patrono C,Coller B,Dalen J E,et al.Platelet active drugs:the relationships among dose,effectiveness,and side effects.Chest,2001,119:239-263.
10Pappas JM,W estengard JC,Bull BS.Population variability in the elect of aspirin on platelet function.Implications for clinical trials and therapy.Arch Pathol Lab Med,1994,118:801-804.
7Fure B, Wyller T B. Emotional symptoms in acute ischernlc stroke[J ]. Int Geriat Psychiatry, 2006, 21 (4) : 382.
8Camerron J I, Chung A M. Stroke survivors' behavioral and psychologic symptoms and associated with informal care- givers' experiences of depression[J ]. Arch Psyc Med Reha- bil, 2006, 87(2): 177.
